Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Medipharm Labs Corp (LABS.TO)

Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Medipharm Labs Corp 151 John Street Barrie ON L4N 2L1 CAN

https://www.medipharmlabs.com P: 705-719-7425

Description:

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically the company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.

Key Statistics

Overview:

Market Capitalization, $K 32,324
Shares Outstanding, K 404,049
Annual Sales, $ 33,062 K
Annual Net Income, $ -13,083 K
Last Quarter Sales, $ 9,131 K
Last Quarter Net Income, $ -2,965 K
60-Month Beta 1.52
% of Institutional Shareholders 0.72%

Growth:

1-Year Return 0.00%
3-Year Return -80.00%
5-Year Return -98.86%
5-Year Revenue Growth 26.52%

Per-Share Information:

Latest Earnings Date 05/20/24
Earnings Per Share ttm -0.04
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -63.64%
Dividend Payout Ratio 0.00%
Most Recent Split 1-2 on 10/04/18

LABS.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -24.00%
Return-on-Assets % -20.22%
Profit Margin % -39.57%
Debt/Equity 0.00
Price/Sales 0.88
Price/Book 0.61
Book Value/Share 0.13
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar